Research Highlights: Adults with COVID-19 infection who were not hospitalized received a prescription strength, purified omega-3 fatty acid to determine if it might reduce ...

Research Highlights: A novel software algorithm developed for wearable devices, such as smartwatches and fitness trackers, was able to detect irregular heart rhythms. ...

Research Highlights: Adults with heart failure who took canagliflozin, a medication originally developed to treat type 2 diabetes, reported improvements in their heart failure ...

Research Highlights: When treated with empagliflozin, adults hospitalized for acute heart failure were 36% more likely to have a clinical benefit, such as a ...